Center for Clinical and Translational Science
The Center for Clinical and Translational Science (CCTS) is a multidisciplinary community committed to bridging scientific discovery with improved clinical care and community health. Guided by a vision to translate research into meaningful health outcomes, CCTS conducts and supports high‑quality, innovative studies across the translational spectrum—from basic and pre‑clinical research to clinical trials and observational studies. This work informs prevention strategies, health care policies, and evidence‑based interventions.
Through education, mentorship, and comprehensive research services—including informatics, team science, data support, and study navigation—CCTS fosters collaboration and accelerates the movement of research into practice, ultimately advancing the health of our communities.
CCTS is also home to the Northern New England Clinical & Translational Research Network (NNE-CTR) grant, led by Cliff Rosen, MD, and Gary Stein, MD.
Featured Research & Programs
PIER
The PIER Program is a Coordinated Specialty Care (CSC) team. This means that being part of the PIER Program offers access to professionals trained in many different disciplines who offer a variety of services. The program provides participants and their families the most high-quality, specialized care that exists in mental health treatment today, integrating participant and family voice in all aspects of the process.
Psychosis in Adolescents & Young Adults
The Center for Clinical and Translational Science advances research on psychosis in adolescents and young adults through the work of Kristen Woodberry, PhD, MSW, a clinical psychologist and early psychosis researcher focused on early identification, stress‑vulnerability pathways, and access to specialized care for youth. Her program integrates innovative methods—including intensive smartphone‑based symptom tracking, multiuser biofeedback tools, and psychometric testing of mental health screens—to better understand emerging psychotic‑spectrum experiences and improve engagement in primary care settings. Dr. Woodberry’s studies also highlight the unique needs of rural youth and explore new early‑contact models such as peer support. In partnership with adolescent medicine and regional collaborators, her team develops practical screening resources and evaluates stepped‑care approaches within MaineHealth’s Early Intervention in Psychosis programming.
CCTS Leaders
Ivette Emery, PhD
Dr. Emery has over 10 years of experience as a clinical and translational researcher. She has participated in the development and launch of over 30 study protocols involving human participants. Dr. Emery also serves as the Associate Lead of the Professional Development Core of the Northern New England Clinical and Translational Research (NNE-CTR) Network and has developed and implemented training programs for early clinical investigators and research navigators.
Clifford J Rosen, MD
Dr. Rosen is a world-renowned researcher in the field of bone metabolism. His laboratory focuses on the study of marrow adiposity and bone formation and he has over twenty years of experience with NIH-funded clinical trials. Dr. Rosen is the co-Principal Investigator of the Northern New England Clinical & Translational Research Network. Dr. Rosen has served on numerous NIH review panels and as editor of scientific journals; he is currently an associate editor at the New England Journal of Medicine and is a standing member of the FDA Endocrinologic and Metabolic Diseases Advisory Committee.
Susan L. Santangelo, ScD
Dr. Santangelo is a psychiatric and genetic epidemiologist who joined Maine Medical Center and MaineHealth Institute for Research (MHIR) in 2013. She also directs the Biostatistics, Epidemiology and Research Design (BERD) Core of the Northern New England Clinical and Translational Research Network (NNE-CTR), based at MHIR and The University of Vermont.
CCTS Investigators
Irwin G Brodsky, MD
Dr. Brodsky is an Endocrinologist who studies clinical diabetes and metabolism. He also serves as Clinical Advisor on the COBRE in Mesenchymal and Neural Regulation of Metabolic Networks at MaineHealth Institute for Research.
Emily L Carter, MD
Dr. Carter is a board-certified Geriatrician who has served as Associate Director of Inpatient Programs for MaineHealth Senior Care since 2017. She leads the inpatient Geriatrics consult service and serves as the Medical Director for the Hospital Elder Life Program (HELP), an evidence-based delirium prevention program for hospitalized older adults.
Alexa K Craig, MD
Alexa Craig, MD, MSc, MS is a Neonatal and Pediatric Neurologist at Maine Medical Center and Maine Medical Partners, a clinical researcher, and the Director of the Barbara Bush Children’s Hospital Scholarship Academy. Dr. Craig’s clinical interest are in the areas of Neonatal Neurocritical Care, specifically neuroprotective treatments such as therapeutic hypothermia and employing telemedicine to eliminate outcome disparities for rural-born newborns.
Robert D Ecker, MD
Dr. Ecker is a neurosurgeon, the Director of the Neuroscience Institute at Maine Medical Center and Principal Site Investigator on several aneurysm and stroke intervention clinical trials, including the national Swift-Prime Study, which treats stroke victims with a promising tool that removes clots from the brain immediately following stroke.
Kathleen M Fairfield, MD
Dr. Fairfield is a Physician Scientist, and Professor of Medicine, Public Health & Community Medicine at Tufts University School of Medicine. She joined MaineHealth Maine Medical Center in 2002. Dr. Fairfield’s research is at the intersection of health equity, health services research, improvement in health care delivery, and population health.
Tom Gridley, PhD
Dr. Gridley has over thirty years of experience studying genes and pathways important for embryonic development in mammals, and the connections between mutations in these genes and congenital and acquired human disease. Dr. Gridley is the Associate Director of the Acute Care COBRE and and Program Administrator for the Northern New England Clinical & Translational Research Network.
Joseph B Kahan, MD
Dr. Kahan is a orthopedic surgeon and practices at MaineHealth Orthopedics and Sports Medicine.
Robert S Kramer, MD
Dr. Kramer is a cardiothoracic surgeon who serves as Associate Director of the MMC Blood Management Program. His research interests include neuropsychological changes associated with cardiopulmonary bypass, perioperative glucose and blood management and cardiac surgery associated with acute kidney injury.
Teresa L May, DO
Dr. May is a neurocritical care physician at MaineHealth. She is the lead scientist on Project 1 of the COBRE in Acute Care Research & Rural Disparities. Her research will examine how MaineHealth can improve rural patient outcomes after cardiac arrest by creating a standard best practice protocol for care.
Susan Miesfeldt, MD
Dr. Miesfeldt is the Medical Director for the Cancer Risk and Prevention Program at MMC. Her research focuses on improving access to cancer prevention and early detection among the underserved as well as genetic risks of cancer, the use of telegenetics as a model of care, and studies of biomarkers of breast cancer to improve early detection and treatment.
Kahsi A. Pedersen, PhD
Kahsi Pedersen is a behavioral scientist and Co- Director of the MHIR Clinical and Translational Research Course. Dr. Pedersen has extensive experience with statistical consulting and advanced structural equation modeling as well as other methods of data reduction, path analysis, and analysis of latent variables.
Scot C Remick, MD
Dr. Remick is based at the MMC Cancer Institute in Scarborough. Dr. Remick leads the Oncology Service Line across the MaineHealth Cancer Care Network and at MMC in collaboration with Michael Bianchi, MHA, VP-Oncology. He is also responsible for standardizing the high quality of care delivered at all MaineHealth institutions by executing a coordinated oncology care model across the system and collaborating in research activities at the MaineHealth Institute for Research.
Chip Reynolds, MD
Dr. Reynolds is an Affiliate Faculty at MaineHealth Institute for Research. Dr. Reynolds is a Distinguished Professor of Psychiatry (Emeritus) at the University of Pittsburgh.
Douglas B Sawyer, MD, PhD
Dr. Sawyer is the Co-Director of the Myocardial Biology & Heart Failure Research Lab and is the Chief Academic Officer at MaineHealth and Interim VP of Research. His research centers on developing therapeutic strategies to enhance myocardial repair after injury.
David B Seder, MD
Dr. Seder, is Director of the Division of Neuro-critical Medicine at MMC. He is also a co-Principal Investigator on the COBRE in Acute Care & Rural Health Research. Dr. Seder investigates ways to minimize brain injury following cardiac arrest and stroke.
David Watson Sobel, MD
Brianna Taylor, PhD
Briana Taylor’s is an Affiliate Faculty at MaineHealth Institute for Research. Her research has focused on associations between sleep patterns and both bio-behavioral and mental-health. Her current focus is to examine sleep patterns and circadian physiology as predictors of adaptive functioning in children and adolescents with autism spectrum disorder (ASD).
Kristen A. Woodberry, PhD, MSW
Kristen Woodberry is a clinical social worker, licensed clinical psychologist, and early psychosis researcher at the MaineHealth Institute for Research and Beth Israel Deaconess Medical Center. With over 25 years of clinical experience with children, adolescents, and families, including pioneering work adapting multifamily psychoeducational group therapies for adolescents and their families, Dr. Woodberry’s research has focused on early intervention in major mental illness.
Jonathan Zuckerman, MD
Dr. Zuckerman is an Emeritus Faculty member. He has a longstanding interest in therapeutic development for cystic fibrosis, and has conducted clinical trials on gene therapy for cystic fibrosis, and on outpatient infection control in adult and pediatric cystic fibrosis programs.
Advancing Data Science Through the New CASCO Research Enclave
Data scientists at the Center for Clinical and Translational Science, Matt Williams and Nikko Zurawski, recently partnered with MaineHealth Information Technology to modernize and expand the MHIR data environment. Supported by an administrative supplement to the Biostatistics, Epidemiology, and Research Design (BERD) Core of the Northern New England Clinical and Translational Research Network grant, this work began in 2023 and responds to the growing need for secure, scalable research computing.
The result is CASCO, a new cloud based research enclave built on Amazon Web Services (AWS). Designed to provide advanced Computation, Analytics, Storage, Collaboration, and Optimization, CASCO enables researchers to manage and analyze extremely large datasets, including genomic information and public resources such as All Payer Claims Data (APCD). It also supports emerging methods in machine learning and natural language processing that were previously difficult to implement within MaineHealth.
Northern New England Clinical & Translational Research Network
Northern New England Clinical & Translational Research Network (NNE-CTR) offers financial and research-related resources for investigators and community members who share the vision of eliminating health disparities and inequities in northern New England.